Learn More
Invitrogen™ IL13RA2 Recombinant Rabbit Monoclonal Antibody (15)

Description
This product is preservative free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%). Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire. This antibody has specificity for Mouse IL13RA2/CD213A2.
Specifications
Specifications
| Antigen | IL13RA2 |
| Applications | ELISA |
| Classification | Recombinant Monoclonal |
| Clone | 15 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative |
| Gene | IL13RA2 |
| Gene Accession No. | O88786 |
| Gene Alias | cancer/testis antigen 19; CD213a2; CT19; IL-13 receptor subunit alpha-2; IL13BP; IL13R; IL-13R; IL-13R subunit alpha-2; IL13RA2; IL-13RA2; IL-13R-alpha-2; interleukin 13 binding protein; interleukin 13 receptor alpha 2; interleukin 13 receptor alpha 2 chain; interleukin 13 receptor alpha chain 2; interleukin 13 receptor subunit alpha 2; interleukin 13 receptor, alpha 2; interleukin-13 receptor subunit alpha-2; interleukin-13 receptor subunit alpha-2-like; interleukin-13-binding protein |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.